Sex Hormones and Related Compounds, Including Hormonal Contraceptives

Caitlin Marie Gibson; Amulya Vanguri Tatachar

doi:10.1016/bs.seda.2018.06.007

Sex Hormones and Related Compounds, Including Hormonal Contraceptives

Caitlin Marie Gibson, Amulya Vanguri Tatachar

Pharmacotherapy

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the January 2017 to December 2017 publications on miscellaneous hormones covers various classes of endocrine drugs, including calcitonin, gonadotropins, gonadotrophin-releasing hormone antagonists, human recombinant growth hormone (somatropin), growth hormone receptor antagonists (pegvisomant), parathyroid hormone, melatonin and analogues, oxytocin and analogues, somatostatin and analogues, tasimelteon, vasopressin and analogues.

Original language	English
Title of host publication	Side Effects of Drugs Annual
Editors	Sidhartha D. Ray
Publisher	Elsevier B.V.
Pages	515-520
Number of pages	6
ISBN (Print)	9780444641199
DOIs	https://doi.org/10.1016/bs.seda.2018.06.007
State	Published - 1 Jan 2018

Publication series

Name	Side Effects of Drugs Annual
Volume	40
ISSN (Print)	0378-6080

Keywords

Abiraterone
Adverse effects
Anastrozole
Androgen deprivation therapy (ADT)
Autoimmune hepatitis (AIH)
C-reactive protein (CRP)
Central serous retinopathy (CSR)
Cyproterone acetate (CPA)
Diethylstilbesterol (DES)
Elevated antinuclear antibodies (ANAs)
Estrogens
Gonadotrophin-releasing hormone antagonists
Hormone replacement therapy (HRT)
Intrauterine devices (IUDs)
Medroxyprogesterone acetate (MPA)
Medroxyprogesterone acetate (MPA)
Norethindrone acetate (NET-A)
Oscillatory photodynamic therapy (OPDT)
Ovarian hyperstimulation syndrome (OHSS)
Palinosopia
Side effects
Testosterone undecanoate
Trenbolone acetate
Type 1 diabetes mellitus (TDM1)

Access to Document

10.1016/bs.seda.2018.06.007

Link to publication in Scopus

Fingerprint Dive into the research topics of 'Sex Hormones and Related Compounds, Including Hormonal Contraceptives'. Together they form a unique fingerprint.

Cite this

Gibson, C. M., & Tatachar, A. V. (2018). Sex Hormones and Related Compounds, Including Hormonal Contraceptives. In S. D. Ray (Ed.), Side Effects of Drugs Annual (pp. 515-520). (Side Effects of Drugs Annual; Vol. 40). Elsevier B.V.. https://doi.org/10.1016/bs.seda.2018.06.007

@inbook{0c84f6cfc15846a3a8365999183c47cb,

title = "Sex Hormones and Related Compounds, Including Hormonal Contraceptives",

abstract = "The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the January 2017 to December 2017 publications on miscellaneous hormones covers various classes of endocrine drugs, including calcitonin, gonadotropins, gonadotrophin-releasing hormone antagonists, human recombinant growth hormone (somatropin), growth hormone receptor antagonists (pegvisomant), parathyroid hormone, melatonin and analogues, oxytocin and analogues, somatostatin and analogues, tasimelteon, vasopressin and analogues.",

keywords = "Abiraterone, Adverse effects, Anastrozole, Androgen deprivation therapy (ADT), Autoimmune hepatitis (AIH), C-reactive protein (CRP), Central serous retinopathy (CSR), Cyproterone acetate (CPA), Diethylstilbesterol (DES), Elevated antinuclear antibodies (ANAs), Estrogens, Gonadotrophin-releasing hormone antagonists, Hormone replacement therapy (HRT), Intrauterine devices (IUDs), Medroxyprogesterone acetate (MPA), Medroxyprogesterone acetate (MPA), Norethindrone acetate (NET-A), Oscillatory photodynamic therapy (OPDT), Ovarian hyperstimulation syndrome (OHSS), Palinosopia, Side effects, Testosterone undecanoate, Trenbolone acetate, Type 1 diabetes mellitus (TDM1)",

author = "Gibson, {Caitlin Marie} and Tatachar, {Amulya Vanguri}",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/bs.seda.2018.06.007",

language = "English",

isbn = "9780444641199",

series = "Side Effects of Drugs Annual",

publisher = "Elsevier B.V.",

pages = "515--520",

editor = "Ray, {Sidhartha D.}",

booktitle = "Side Effects of Drugs Annual",

}

TY - CHAP

T1 - Sex Hormones and Related Compounds, Including Hormonal Contraceptives

AU - Gibson, Caitlin Marie

AU - Tatachar, Amulya Vanguri

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the January 2017 to December 2017 publications on miscellaneous hormones covers various classes of endocrine drugs, including calcitonin, gonadotropins, gonadotrophin-releasing hormone antagonists, human recombinant growth hormone (somatropin), growth hormone receptor antagonists (pegvisomant), parathyroid hormone, melatonin and analogues, oxytocin and analogues, somatostatin and analogues, tasimelteon, vasopressin and analogues.

AB - The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the January 2017 to December 2017 publications on miscellaneous hormones covers various classes of endocrine drugs, including calcitonin, gonadotropins, gonadotrophin-releasing hormone antagonists, human recombinant growth hormone (somatropin), growth hormone receptor antagonists (pegvisomant), parathyroid hormone, melatonin and analogues, oxytocin and analogues, somatostatin and analogues, tasimelteon, vasopressin and analogues.

KW - Abiraterone

KW - Adverse effects

KW - Anastrozole

KW - Androgen deprivation therapy (ADT)

KW - Autoimmune hepatitis (AIH)

KW - C-reactive protein (CRP)

KW - Central serous retinopathy (CSR)

KW - Cyproterone acetate (CPA)

KW - Diethylstilbesterol (DES)

KW - Elevated antinuclear antibodies (ANAs)

KW - Estrogens

KW - Gonadotrophin-releasing hormone antagonists

KW - Hormone replacement therapy (HRT)

KW - Intrauterine devices (IUDs)

KW - Medroxyprogesterone acetate (MPA)

KW - Norethindrone acetate (NET-A)

KW - Oscillatory photodynamic therapy (OPDT)

KW - Ovarian hyperstimulation syndrome (OHSS)

KW - Palinosopia

KW - Side effects

KW - Testosterone undecanoate

KW - Trenbolone acetate

KW - Type 1 diabetes mellitus (TDM1)

UR - http://www.scopus.com/inward/record.url?scp=85051038578&partnerID=8YFLogxK

U2 - 10.1016/bs.seda.2018.06.007

DO - 10.1016/bs.seda.2018.06.007

M3 - Chapter

AN - SCOPUS:85051038578

SN - 9780444641199

T3 - Side Effects of Drugs Annual

SP - 515

EP - 520

BT - Side Effects of Drugs Annual

A2 - Ray, Sidhartha D.

PB - Elsevier B.V.

ER -